MedTrace Logo

Bone Microstructure in Nasal Salmon Calcitonin Treated Postmenopausal Women

NCT00372099 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2011-12-23

No results posted yet for this study

Summary

Calcitonin has been used for many years for treating osteoporosis in postmenopausal women. Recent data from the 2 years placebo-controlled QUEST study have shown a preservation of microarchitecture as measured by high resolution MRI in postmenopausal women with prevalent vertebral fractures at baseline.This pilot study should provide additional new insights in the mode of action of nasal calcitonin, on structural changes as measured by high resolution peripheral CT, and on the comparison between weight bearing and non weight bearing bones in postmenopausal women.

Conditions

  • Postmenopause

Interventions

DRUG

Salmon calcitonin

nasal salmon calcitonin 200UI/day during 2 years

Sponsors & Collaborators

  • Rene Rizzoli

    lead OTHER

Principal Investigators

  • René Rizzoli, Professor · Department of Rehabilitation and Geriatrics, University Hospital of Geneva

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2011-10-31
Completion
2011-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00372099 on ClinicalTrials.gov